ID   I17RE_HUMAN             Reviewed;         667 AA.
AC   Q8NFR9; B2RB34; B2RNR1; B9EH65; Q6P532; Q8N8H7; Q8N8H8; Q8TEC2;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-JUN-2023, entry version 137.
DE   RecName: Full=Interleukin-17 receptor E;
DE            Short=IL-17 receptor E;
DE            Short=IL-17RE;
DE   Flags: Precursor;
GN   Name=IL17RE; ORFNames=UNQ3056/PRO9877;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Gilbert J.M., Gorman D.M.;
RT   "Identification of novel IL-17 related receptors.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Colon mucosa, Prostate, and Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   TISSUE=Lung, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=16310341; DOI=10.1016/j.cellsig.2005.10.010;
RA   Li T.-S., Li X.-N., Chang Z.-J., Fu X.-Y., Liu L.;
RT   "Identification and functional characterization of a novel interleukin 17
RT   receptor: a possible mitogenic activation through ras/mitogen-activated
RT   protein kinase signaling pathway.";
RL   Cell. Signal. 18:1287-1298(2006).
RN   [7]
RP   FUNCTION, AND IDENTIFICATION AS IL17C RECEPTOR.
RX   PubMed=21993849; DOI=10.1038/ni.2155;
RA   Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., Qian Y.;
RT   "IL-17RE is the functional receptor for IL-17C and mediates mucosal
RT   immunity to infection with intestinal pathogens.";
RL   Nat. Immunol. 12:1151-1158(2011).
RN   [8]
RP   FUNCTION, IDENTIFICATION AS IL17C RECEPTOR, INTERACTION WITH IL17RA, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=21993848; DOI=10.1038/ni.2156;
RA   Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J.,
RA   Hackney J., Kim J., Zhou M., Lai J., Modrusan Z., Sai T., Lee W., Xu M.,
RA   Caplazi P., Diehl L., de Voss J., Balazs M., Gonzalez L. Jr., Singh H.,
RA   Ouyang W., Pappu R.;
RT   "IL-17C regulates the innate immune function of epithelial cells in an
RT   autocrine manner.";
RL   Nat. Immunol. 12:1159-1166(2011).
CC   -!- FUNCTION: Specific functional receptor for IL17C. May be signaling
CC       through the NF-kappa-B and MAPK pathways. May require TRAF3IP2 /ACT1
CC       for signaling. May be a crucial regulator in innate immunity to
CC       bacterial pathogens. Isoform 2 and isoform 4 may be either cytoplasmic
CC       inactive or dominant active forms. Isoform 3 and isoform 5 may act as
CC       soluble decoy receptors. {ECO:0000269|PubMed:21993848,
CC       ECO:0000269|PubMed:21993849}.
CC   -!- SUBUNIT: Forms heterodimers with IL17RA; the heterodimer binds IL17C.
CC   -!- INTERACTION:
CC       Q8NFR9; Q96F46: IL17RA; NbExp=2; IntAct=EBI-5591275, EBI-5591258;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000250}; Single-
CC       pass type I membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8NFR9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NFR9-2; Sequence=VSP_029190;
CC       Name=3;
CC         IsoId=Q8NFR9-3; Sequence=VSP_029193, VSP_029196;
CC       Name=4;
CC         IsoId=Q8NFR9-4; Sequence=VSP_029190, VSP_029194, VSP_029195;
CC       Name=5;
CC         IsoId=Q8NFR9-5; Sequence=VSP_029191, VSP_029192;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in mucosal tissues with
CC       high levels in keratinocytes and colon epithelial cells. Very low
CC       expression in dermal fibroblasts. Expressed in various tumor cell
CC       lines. {ECO:0000269|PubMed:16310341, ECO:0000269|PubMed:21993848}.
CC   -!- SEQUENCE CAUTION: [Isoform 3]:
CC       Sequence=BAB85028.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF458069; AAM77573.1; -; mRNA.
DR   EMBL; AY358451; AAQ88816.1; -; mRNA.
DR   EMBL; AK074238; BAB85028.1; ALT_FRAME; mRNA.
DR   EMBL; AK096793; BAC04863.1; -; mRNA.
DR   EMBL; AK096801; BAC04864.1; -; mRNA.
DR   EMBL; AK314476; BAG37081.1; -; mRNA.
DR   EMBL; CH471055; EAW64019.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64020.1; -; Genomic_DNA.
DR   EMBL; CH471055; EAW64016.1; -; Genomic_DNA.
DR   EMBL; BC063110; AAH63110.1; -; mRNA.
DR   EMBL; BC137077; AAI37078.1; -; mRNA.
DR   EMBL; BC137078; AAI37079.1; -; mRNA.
DR   CCDS; CCDS2589.1; -. [Q8NFR9-1]
DR   CCDS; CCDS54552.1; -. [Q8NFR9-3]
DR   RefSeq; NP_001180309.1; NM_001193380.1. [Q8NFR9-3]
DR   RefSeq; NP_705613.1; NM_153480.1. [Q8NFR9-1]
DR   RefSeq; NP_705614.1; NM_153481.1. [Q8NFR9-2]
DR   RefSeq; NP_705616.2; NM_153483.2.
DR   RefSeq; XP_006713039.1; XM_006712976.1. [Q8NFR9-2]
DR   AlphaFoldDB; Q8NFR9; -.
DR   SMR; Q8NFR9; -.
DR   BioGRID; 126304; 26.
DR   IntAct; Q8NFR9; 10.
DR   STRING; 9606.ENSP00000373325; -.
DR   GlyCosmos; Q8NFR9; 3 sites, No reported glycans.
DR   GlyGen; Q8NFR9; 3 sites.
DR   iPTMnet; Q8NFR9; -.
DR   PhosphoSitePlus; Q8NFR9; -.
DR   BioMuta; IL17RE; -.
DR   DMDM; 74730297; -.
DR   MassIVE; Q8NFR9; -.
DR   PaxDb; Q8NFR9; -.
DR   PeptideAtlas; Q8NFR9; -.
DR   ProteomicsDB; 73342; -. [Q8NFR9-1]
DR   ProteomicsDB; 73343; -. [Q8NFR9-2]
DR   Antibodypedia; 2563; 341 antibodies from 31 providers.
DR   DNASU; 132014; -.
DR   Ensembl; ENST00000383814.8; ENSP00000373325.3; ENSG00000163701.19. [Q8NFR9-1]
DR   Ensembl; ENST00000454190.6; ENSP00000388086.2; ENSG00000163701.19. [Q8NFR9-3]
DR   GeneID; 132014; -.
DR   KEGG; hsa:132014; -.
DR   MANE-Select; ENST00000383814.8; ENSP00000373325.3; NM_153480.2; NP_705613.1.
DR   UCSC; uc003btw.4; human. [Q8NFR9-1]
DR   AGR; HGNC:18439; -.
DR   CTD; 132014; -.
DR   DisGeNET; 132014; -.
DR   GeneCards; IL17RE; -.
DR   HGNC; HGNC:18439; IL17RE.
DR   HPA; ENSG00000163701; Tissue enhanced (intestine, skin).
DR   MIM; 614995; gene.
DR   neXtProt; NX_Q8NFR9; -.
DR   OpenTargets; ENSG00000163701; -.
DR   PharmGKB; PA134896136; -.
DR   VEuPathDB; HostDB:ENSG00000163701; -.
DR   eggNOG; ENOG502QU0I; Eukaryota.
DR   GeneTree; ENSGT00940000161421; -.
DR   HOGENOM; CLU_026094_0_0_1; -.
DR   InParanoid; Q8NFR9; -.
DR   OMA; CVEVYYT; -.
DR   OrthoDB; 5310632at2759; -.
DR   PhylomeDB; Q8NFR9; -.
DR   TreeFam; TF335690; -.
DR   PathwayCommons; Q8NFR9; -.
DR   Reactome; R-HSA-448424; Interleukin-17 signaling.
DR   SignaLink; Q8NFR9; -.
DR   BioGRID-ORCS; 132014; 12 hits in 1145 CRISPR screens.
DR   GenomeRNAi; 132014; -.
DR   Pharos; Q8NFR9; Tbio.
DR   PRO; PR:Q8NFR9; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8NFR9; protein.
DR   Bgee; ENSG00000163701; Expressed in skin of leg and 92 other tissues.
DR   ExpressionAtlas; Q8NFR9; baseline and differential.
DR   Genevisible; Q8NFR9; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030368; F:interleukin-17 receptor activity; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.11530; -; 1.
DR   InterPro; IPR039465; IL-17_rcpt-like.
DR   InterPro; IPR027841; IL-17_rcpt_C/E_N.
DR   InterPro; IPR013568; SEFIR_dom.
DR   PANTHER; PTHR15583; INTERLEUKIN-17 RECEPTOR; 1.
DR   PANTHER; PTHR15583:SF5; INTERLEUKIN-17 RECEPTOR E; 1.
DR   Pfam; PF15037; IL17_R_N; 1.
DR   Pfam; PF08357; SEFIR; 2.
DR   PROSITE; PS51534; SEFIR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Glycoprotein;
KW   Inflammatory response; Membrane; Receptor; Reference proteome; Secreted;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..667
FT                   /note="Interleukin-17 receptor E"
FT                   /id="PRO_0000309467"
FT   TOPO_DOM        24..454
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        455..475
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        476..667
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          487..624
FT                   /note="SEFIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00867"
FT   REGION          126..174
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        126..158
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        318
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        364
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..116
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029190"
FT   VAR_SEQ         268..271
FT                   /note="YGSD -> CECC (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029191"
FT   VAR_SEQ         272..667
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029192"
FT   VAR_SEQ         433..533
FT                   /note="VWRSDVQFAWKHLLCPDVSYRHLGLLILALLALLTLLGVVLALTCRRPQSGP
FT                   GPARPVLLLHAADSEAQRRLVGALAELLRAALGGGRDVIVDLWEGRHVA -> LHASLS
FT                   SPGGEDAWLIGVGGSVPSGVAVRCPVCLEAPLVSGCLLQTPGALDPGTAGPPHPTGCCS
FT                   GPHLPAPTVRPGPSAASAPPARGGLGGAAAPGGSAG (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029193"
FT   VAR_SEQ         433..506
FT                   /note="VWRSDVQFAWKHLLCPDVSYRHLGLLILALLALLTLLGVVLALTCRRPQSGP
FT                   GPARPVLLLHAADSEAQRRLVG -> ASSWSRHKPTWEEFPSQWGLPSPPAPCFTQLPG
FT                   RRRCLAHRGGGLCALRCGGQMSSLPGSTSCVRMSLTDTWGS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029194"
FT   VAR_SEQ         507..667
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029195"
FT   VAR_SEQ         534..667
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_029196"
FT   VARIANT         219
FT                   /note="Y -> C (in dbSNP:rs7356031)"
FT                   /id="VAR_036956"
FT   VARIANT         402
FT                   /note="P -> S (in dbSNP:rs9870003)"
FT                   /id="VAR_036957"
FT   VARIANT         417
FT                   /note="S -> T (in dbSNP:rs7647642)"
FT                   /id="VAR_036958"
FT   CONFLICT        270
FT                   /note="S -> P (in Ref. 3; BAC04864)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="L -> F (in Ref. 3; BAC04864)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   667 AA;  74810 MW;  1493744E7354067D CRC64;
     MGSSRLAALL LPLLLIVIDL SDSAGIGFRH LPHWNTRCPL ASHTDDSFTG SSAYIPCRTW
     WALFSTKPWC VRVWHCSRCL CQHLLSGGSG LQRGLFHLLV QKSKKSSTFK FYRRHKMPAP
     AQRKLLPRRH LSEKSHHISI PSPDISHKGL RSKRTQPSDP ETWESLPRLD SQRHGGPEFS
     FDLLPEARAI RVTISSGPEV SVRLCHQWAL ECEELSSPYD VQKIVSGGHT VELPYEFLLP
     CLCIEASYLQ EDTVRRKKCP FQSWPEAYGS DFWKSVHFTD YSQHTQMVMA LTLRCPLKLE
     AALCQRHDWH TLCKDLPNAT ARESDGWYVL EKVDLHPQLC FKFSFGNSSH VECPHQTGSL
     TSWNVSMDTQ AQQLILHFSS RMHATFSAAW SLPGLGQDTL VPPVYTVSQA RGSSPVSLDL
     IIPFLRPGCC VLVWRSDVQF AWKHLLCPDV SYRHLGLLIL ALLALLTLLG VVLALTCRRP
     QSGPGPARPV LLLHAADSEA QRRLVGALAE LLRAALGGGR DVIVDLWEGR HVARVGPLPW
     LWAARTRVAR EQGTVLLLWS GADLRPVSGP DPRAAPLLAL LHAAPRPLLL LAYFSRLCAK
     GDIPPPLRAL PRYRLLRDLP RLLRALDARP FAEATSWGRL GARQRRQSRL ELCSRLEREA
     ARLADLG
//
